【レポートの概要（一部）】
1. Report Overview
1.1 Biobanking for Medicine: World Market Review 2015 and Global Segmentation
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 Defining the Human Tissue Banking Market for the Scope of this Report
2.2 The Stem Cell Banking Market – Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 The Guidelines and Standards for Biobanking
2.8 Laws and Regulations for Biobank-Based Research
2.8.1 HIPAA Amendments
2.9 Biobanking and the Pharmaceutical Industry
2.9.1 Biobanking in Research, Drug Discovery and Development
2.9.1.1 Biobanking – Facilitates Genetic Epidemiology Studies
2.9.1.2 Novel Drug Discovery through Better Understanding of Disease Pathways
2.9.1.3 Biomarker Discovery in Drug Development
2.9.2 Biobanking for Therapeutic Purposes
2.9.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2015 to 2026
3.1 The World Biobanking for Medicine Market in 2015
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2020 and 2026
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2015 to 2026
3.4 Biobanks Stored More Than 1.4 Billion Specimens in 2015
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2015 to 2026
3.6 Biobanking for Research: Mostly Non-Profit
3.6.1 Biobanking for Research: Revenue Forecast 2015 to 2026
3.6.2 Driving Forces: Outweighs Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: Is It Too Commercial?
3.7.1 Arguments against Commercial Stem Cell Banking for Therapeutic Uses
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2015 to 2026
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Applications, 2015 to 2026
4. Biobanking for Research Purposes
4.1 Breakdown of Biobanking for Research Market by Tissue Type, 2015
4.2 Biobanking for Research in 2020 and 2026: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2015 to 2026
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2015
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2015 to 2026
4.7 The Human Tissue Banking Market: Commercial vs. Public Sectors
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2015 to 2026
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2015 to 2026
4.8 The Stem Cell Banking Market for Research in 2015
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2015 to 2026
4.9.1 R&D- Growing Interest Towards iPSCs
4.10 Banking of Other Biologics Specimens for Research in 2015
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2015 to 2026
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2015: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2020 and 2026
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts
5.4 How Many Stem Cells Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2015
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2015 to 2026
5.7 The Adult Stem Cell Banking Market in 2015
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2015 to 2026
6. Leading National Markets 2015 to 2026
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Fast Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2015
6.3 The Leading National Markets: Grouped Revenue Forecasts 2015 to 2026
6.4 How Will Regional Market Shares Change to 2026?
6.5 The US Biobanking Market 2015 to 2026: Diversifying and Expanding
6.6 The Top European Biobanking Markets 2015 to 2026: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: Limited Presence of Biobanking Networks
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2015 to 2026: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share between 2015 and 2026
6.8.1 The Chinese Biobanking Market 2015 to 2026: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2015 to 2026: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2015 to 2026: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2015 to 2026?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated with Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: Sustainability, Easy Sample Tracking, and Added Security
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2015
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand Bioscience is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, BioSpoke and PhaseZERO
8.2.2.2 The Future Outlook for Asterand
8.2.3 Biopta: Human Tissue Provider Now Acquired by Japanese Company ReproCELL
8.2.3.1 Services from Biopta: A Variety of Lab Services and Fresh Tissue Sample Procurement
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta: Fresh Tissue Will Be in Demand
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of and Recent Developments at Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2015
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled, Strategic Alternatives Being Considered
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences Is Under a New Owner
8.3.5 LifebankUSA: Acquisition from Human Longevity Inc Will Potentially Drive Growth
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company Will Be Promoted By New Parent Company
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Reportedly Facing Challenges Due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 Caladrius Biosciences (formerly NeoStem): More Focus on Cell Therapy Than Stem Cell Banking
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Market 2015 to 2026
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2015
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 The Effect of Big Data on Biobanking
9.2.5 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.6 Biobanks are Fragmented and Uncoordinated
9.2.7 Lack of Standardisation is a Weakness of the Industry
9.2.8 Lack of Public Awareness Limits Number of Donors
9.2.9 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2015 to 2026
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long-Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2015 to 2026
10. Research Interviews
10.1 Mr Veselin D. Stefanov, MBA, General Manager, Fidelis Research, Bulgaria
10.1.1 Fidelis Research – Specialists in Human Tissue Procurement With a Strong Network of Partners
10.1.2 Challenges in Tissue Procurement Stem from a Lack of Legislation
10.1.3 Lack of Standardisation Causing Decreased Demand for Biobanked Tissues
10.1.4 Significant Therapeutic Areas of Demand
10.1.5 Essential Qualities for a Successful Tissue Procurement Service
10.1.6 The Impact of Trends in Biobanking
10.2 Dr Jeanne-Hélène di Donato, 3C-R, France
10.2.1 French Biobanks – a Network of Specialized Biobanks
10.2.2 Biobanking Management –Promoting Scientific Value of Collections
10.2.3 Harmonization – Scientific Valorisation
10.2.4 Bioethical – Diverse Views and Policies on Consent
10.2.5 Broad Consent –Is This the Best Option?
10.2.6 3C-R – Services and Solutions for Biobanks
10.3 Dr Luis Nacul and Dr Eliana Lacerda, UK ME/CFS Biobank Project
10.3.1 UK ME/CFS Biobank – Objectives and Activities
10.3.2 Biobank Resource – Available for External Researchers in August 2015
10.3.3 Main Issue – Sustainability
10.3.4 Unmet Needs – Awareness from Government and General Public
11. Conclusions from Our Research and Analysis
11.1 World Biobanking Market 2015 to 2026: High Revenue Growth Predicted
11.2 Biobanking for Research 2015 to 2026: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2015 to 2026: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples – Increasing Revenue
11.5.2 Improving Biobanking Infrastructure – Growth Driver and a Need for Strategic Planning for Sustainability
11.5.3 Marked Challenges, but Opportunities for Expansion
【レポート販売概要】
■ タイトル：バイオバンクの世界市場予測2016-2026■ 英文：Biobanking Market Forecasts 2016-2026
■ 発行日：2016年4月
■ 調査会社：visiongain
■ 商品コード：VGAIN60628
■ 調査対象地域：グローバル
- 緑茶の世界市場2018-2022About Green Tea Green tea is a tea made from unfermented leaves of Camellia sinensis that have not undergone the same withering and oxidation processes, which are typically used to make oolong and black tea. Pale in color and slightly bitter in flavor, green tea is a variety of tea that originated in China. Technavio’s analysts forecast the global green tea market to grow at a CAGR of 5.68% during …
- ウィルムス腫瘍 (腎芽細胞腫)：グローバル臨床試験レビューH2, 2013Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013" provides data on the Wilms’ Tumor (Nephroblastoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wilms’ Tumor (Nephroblastoma). It includes an overv …
- Animal Health Market 2014: Global Trends and Strategies of Key SuppliersThis new 42-page report from Venture Planning Group analyzes global trends and strategies of the world’s leading animal health companies, including:Five-year forecasts for: - Major market segments - Key geographic regionsAssessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussio …
- Petroleo Brasileiro S.A.：石油・ガスバリューチェーン分析レポート2013Petroleo Brasileiro S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Petroleo Brasileiro S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Petroleo Brasileiro S.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The …
- リチウムの世界市場2018-2022About Lithium Lithium (Li) is a silvery-white metal, and it is the lightest of all elements at room temperature. Though it does not occur as a pure element in nature, it is mainly contained within salts or mineral deposits. Technavio’s analysts forecast the global lithium market to grow at a CAGR of 12.93% during the period 2018-2022. Covered in this report The report covers the present scenario a …
- 漂白活性化Earthの世界市場Activated Bleaching Earth (CAS 70131-50-9) Market Research Report 2013 presents comprehensive data on activated bleaching earth markets globally and regionally (Europe, Asia, North America etc.) The Activated Bleaching Earth (CAS 70131-50-9) Market Research Report 2013 includes activated bleaching earth description, covers its application areas and related patterns. It overviews activated bleachin …
- 防火装置の世界市場予測（～2022年）：センサー、火災感知器、RFID、スプリンクラー設備、消火器In today’s modern and dynamic world of technology, fire accidents have been increasing with the growth of high energy-efficient buildings. The fire accidents are prevented by the use of various fire protection systems such as fire alarm and detection systems, fire sprinkler systems, and fire extinguishers. The demand for fire protection systems has grown considerably in the last decade since most …
- ブースターコンプレッサーの世界市場予測（～2023年）The global booster compressor market is projected to reach a market size of USD 2.39 Billion in 2023, growing at a CAGR of 4.50%, from an estimated USD 1.92 Billion in 2018. Booster compressors are used in different applications in industries such as air boosting, gas bosting, air separation, and compression of gases for storage and transportation. Thus, the growing industrialization in developing …
- カボチャ種子の世界市場About Pumpkin SeedsPumpkin seeds are the edible kernels of pumpkins. The seeds are concentrated sources of many vitamins, minerals, antioxidants, and vital amino acids. They contain zinc, magnesium, copper, and iron in substantial quantities. They can be found in various forms: hulled, roasted, and raw. Technavio’s analysts forecast the global Pumpkin Seeds market to grow at a CAGR of 15.07% durin …
- 世界の3Dディスプレイー市場：Global 3D Display Market 2014-2018TechNavio forecasts The Global 3D Display Market 2014-2018 with a CAGR of 25.7 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provide …
- 世界の鉄道産業におけるIT支出市場About Information Technology Spending in Railways Railway infrastructure plays a vital role in the economic and social development of a country. Globally, the traffic congestion on roads has increased. As a result, people choose trains as a mode of transportation as it is a more feasible and convenient option, especially for long-distance traveling. The rise in passenger and freight traffic has le …
- 酸化プロピレン(PO)の世界市場予測Propylene oxide 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about propylene oxide market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytica …
- 小売分析の世界市場：業務機能（マーケティング/顧客分析、マーチャンダイジング/インストア分析、サプライチェーン分析、戦略、企画）、種類、ソリューション、サービスMarketsandMarkets forecast the retail analytics market size growth from USD 2.2 Billion in 2015 to USD 5.1 Billion by 2020, at a compound annual growth rate (CAGR) of 18.9% from 2015 to 2020. Due to digitalization there is continuous rise in volume, variety and velocity of data in retail sector, and to analyze these data there is high demand for the solutions and services of retail analytics, driv …
- シェールガス処理装置の世界市場：コンポーネント別（内燃機関、圧縮機・ポンプ、電動機械、熱交換器、測定・制御装置、その他）、地域別予測Global Shale Gas Processing Equipment Market to reach USD 12.97 billion by 2025. Global Shale Gas Processing Equipment Market valued approximately USD 3.19 billion in 2016 is forecasted to grow with a healthy growth rate of more than 16.87% over the forecast period 2018-2025. The major factors speculated to augment the markets are escalating energy requirements, improvements in drilling technology …
- 2014年戦略提言：日本の輸血診断検査市場Complete report $7,700. DataPack (test volumes, sales forecasts, supplier shares) $4,950.This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the Japanese transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and …
